Skip to main content
Log in

Adrenal Metastectomy is Safe in Selected Patients

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

The benefit of adrenalectomy (ADX) for adrenal metastasis is not established. We evaluated outcomes after ADX for patients with adrenal metastasis.

Methods

We retrospectively analyzed the records of 90 patients who underwent ADX for metastatic disease. Overall survival (OS) after ADX was calculated using the Kaplan–Meier method. Clinical factors were evaluated for associations with OS using a Cox regression model, and with operative factors using the Wilcoxon two-sample or Fisher’s exact test.

Results

The most common primary tumor types were melanoma (35, 39 %) and lung cancer (32, 35 %). A total of 49 (54 %) patients had isolated adrenal metastasis; 55 (61 %) underwent laparoscopic resection (LADX). Median OS was 2.46 years (range < 1 month–15 years), and 5-year survival rate was 38 % (6 % standard error). Most patients experienced disease progression (56, 62 %) despite achieving disease-free status following ADX (78, 86 %). When compared with the open approach, LADX was associated with smaller tumor size, as well as reduced blood loss, operative time, and length of stay (all p < 0.0001), and no difference in OS (p = 0.4122) or complications (p = 1). Isolated adrenal bed recurrence was similar in LADX (N = 3, 5 %) and open ADX (N = 2, 6 %) (p = 1), and did not affect OS (p = 0.2). Larger tumors were associated with shorter median OS (p = 0.0014).

Conclusions

ADX for metastasis can be safely performed in selected patients. Some patients with adrenal metastasis achieve prolonged survival following ADX. Compared with an open approach, LADX has no measurable oncologic disadvantage, minimizes morbidity, and should be considered when tumor characteristics permit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma: analysis of 1000 autopsied cases. Cancer 3(1):74–85

    Article  CAS  PubMed  Google Scholar 

  2. Lo CY, VanHeerden JA, Soreide JA et al (1996) Adrenalectomy for metastatic disease to the adrenal glands. Br J Surg 83:528–531

    Article  CAS  PubMed  Google Scholar 

  3. Lam KY, Lo CY (2002) Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital. Clin Endocrinol 56:95–101

    Article  Google Scholar 

  4. Aron D, Terzolo M, Cawood TJ (2012) Adrenal incidentalomas. Best Pract Res Clin Endocrinol Metab 26:69–82

    Article  PubMed  Google Scholar 

  5. No authors listed (2002) NIH state-of-the-science statement on management of the clinically inapparent adrenal mass (“Incidentaloma”) NIH Consens State Sci Statements 19(2):1–23

    Google Scholar 

  6. Lenert JE, Barnett CC, Kudelka AP et al (2001) Evaluation and surgical resection of adrenal masses in patients with a history of extra-adrenal malignancy. Surgery 130:1060–1067

    Article  CAS  PubMed  Google Scholar 

  7. Zeiger MA, Thompson GB, Duh QY et al (2009) AACE/AAES adrenal incidentaloma guidelines. Endocr Pract 15(5):450–453

    Article  PubMed  Google Scholar 

  8. Mittendorf EA, Lim SJ, Schacherer CW et al (2008) Melanoma adrenal metastasis: natural history and surgical management. Am J Surg 195:363–369

    Article  PubMed  Google Scholar 

  9. Vazquez BJ, Richards ML, Lohse CM et al (2012) Adrenalectomy improves outcomes of selected patients with metastatic carcinoma. World J Surg 36:1400–1405

    Article  PubMed  Google Scholar 

  10. Moreno P, de la Quintana Basarrate A, Musholt TJ et al (2013) Adrenalectomy for solid tumor metastases: results of a multicenter European study. Abstract presented at American Association of Endocrine Surgeons, Chicago (IL), April 14

  11. Heniford BT, Arca MJ, Walsh RM et al (1999) Laparoscopic adrenalectomy for cancer. Semin Surg Onc 16:293–306

    Article  CAS  Google Scholar 

  12. Luketich JD, Burt ME (1996) Does resection of adrenal metastases from non-small cell lung cancer improve survival? Ann Thorac Surg 63:1614–1616

    Article  Google Scholar 

  13. Strong VE, D’angelica M, Tang L et al (2007) Laparoscopic adrenalectomy for isolated adrenal metastasis. Annals Surg Onc 14:3392–3400

    Article  Google Scholar 

  14. Perrier ND, Kennamer DL, Bao R et al (2008) Posterior retroperitoneoscopic adrenalectomy: preferred technique for removal of benign tumors and isolated metastases. Annals Surg 248:666–674

    Google Scholar 

Download references

Acknowledgments

The authors would like to thank Mr. Roland Bassett for his assistance on the statistical analysis and Ms. Melissa Burkett for editorial assistance in manuscript preparation.

Conflict of interest

The authors have no conflicts of interest to disclose.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Minerva Angelica Romero Arenas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Romero Arenas, M.A., Sui, D., Grubbs, E.G. et al. Adrenal Metastectomy is Safe in Selected Patients. World J Surg 38, 1336–1342 (2014). https://doi.org/10.1007/s00268-014-2454-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-014-2454-x

Keywords

Navigation